Preparation of small amounts of sterile siRNA-liposomes with high entrapping efficiency by dual asymmetric centrifugation (DAC)

Journal of Controlled Release

Volumn 135, Issue 1, 2009, Pages 80-88

  Hirsch, Markus ^a,b   Ziroli, Vittorio ^a   Helm, Mark ^b   Massing, Ulrich ^a  

^a TUMOR BIOLOGY CENTER   (Germany)

^b UNIVERSITY OF HEIDELBERG   (Germany)

Author keywords

DAC; Dual asymmetric centrifugation; Liposome; Preparation; siRNA; Sterile

Indexed keywords

DAC; DUAL ASYMMETRIC CENTRIFUGATION; PREPARATION; SIRNA; STERILE;

CENTRIFUGATION; CENTRIFUGES; DIGITAL INTEGRATED CIRCUITS; ENERGY TRANSFER; FLUORESCENCE; NUCLEIC ACIDS; PHOSPHOLIPIDS; RNA; SONOLUMINESCENCE;

LIPOSOMES;

CALCEIN; FLUORESCENT DYE; LIPID; LIPOSOME; SMALL INTERFERING RNA;

ARTICLE; CENTRIFUGATION; DRUG FORMULATION; DRUG STABILITY; DRUG STRUCTURE; DRUG SYNTHESIS; DUAL ASYMMETRIC CENTRIFUGATION; FLUORESCENCE RESONANCE ENERGY TRANSFER; PRIORITY JOURNAL; STRUCTURE ANALYSIS;

CENTRIFUGATION; CHROMATOGRAPHY, HIGH PRESSURE LIQUID; DRUG COMPOUNDING; DRUG STABILITY; FLUORESCEINS; FLUORESCENCE RESONANCE ENERGY TRANSFER; LIPOSOMES; PARTICLE SIZE; RNA, SMALL INTERFERING; SPECTROMETRY, FLUORESCENCE; STERILIZATION;

EID: 61649100705     PISSN: 01683659     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jconrel.2008.11.029     Document Type: Article

References (37)

1. Fire A., Xu S., Montgomery M.K., Kostas S.A., Driver S.E., and Mello C.C. Potent and specific genetic interference by double-stranded RNA in caenorhabditis elegans. Nature 391 6669 (1998) 806-811
2. Kurreck J. Antisense technologies. Improvement through novel chemical modifications. Eur. J. Biochem. 270 8 (2003) 1628-1644
3. Mittal V. Improving the efficiency of RNA interference in mammals. Nat. Rev., Genet. 5 5 (2004) 355-365
4. Kawakami S., and Hashida M. Targeted delivery systems of small interfering RNA by systemic administration. Drug Metab. Pharmacokinet 22 3 (2007) 142-151
5. Regelin A.E., Fankhaenel S., Gurtesch L., Prinz C., von Kiedrowski G., and Massing U. Biophysical and lipofection studies of dotap analogs. Biochim. Biophys. Acta 1464 1 (2000) 151-164
6. Bumcrot D., Manoharan M., Koteliansky V., and Sah D.W. RNAi therapeutics: A potential new class of pharmaceutical drugs. Nat. Chem. Biol. 2 12 (2006) 711-719
7. Zimmermann T.S., Lee A.C., Akinc A., Bramlage B., Bumcrot D., Fedoruk M.N., Harborth J., Heyes J.A., Jeffs L.B., John M., Judge A.D., Lam K., McClintock K., Nechev L.V., Palmer L.R., Racie T., Rohl I., Seiffert S., Shanmugam S., Sood V., Soutschek J., Toudjarska I., Wheat A.J., Yaworski E., Zedalis W., Koteliansky V., Manoharan M., Vornlocher H.P., and MacLachlan I. RNAi-mediated gene silencing in non-human primates. Nature 441 7089 (2006) 111-114
8. Merritt W.M., Lin Y.G., Spannuth W.A., Fletcher M.S., Kamat A.A., Han L.Y., Landen C.N., Jennings N., De Geest K., Langley R.R., Villares G., Sanguino A., Lutgendorf S.K., Lopez-Berestein G., Bar-Eli M.M., and Sood A.K. Effect of interleukin-8 gene silencing with liposome-encapsulated small interfering RNA on ovarian cancer cell growth. J. Natl. Cancer Inst. 100 5 (2008) 359-372
9. Halder J., Kamat A.A., Landen Jr. C.N., Han L.Y., Lutgendorf S.K., Lin Y.G., Merritt W.M., Jennings N.B., Chavez-Reyes A., Coleman R.L., Gershenson D.M., Schmandt R., Cole S.W., Lopez-Berestein G., and Sood A.K. Focal adhesion kinase targeting using in vivo short interfering RNA delivery in neutral liposomes for ovarian carcinoma therapy. Clin. Cancer Res. 12 16 (2006) 4916-4924
10. Landen Jr. C.N., Chavez-Reyes A., Bucana C., Schmandt R., Deavers M.T., Lopez-Berestein G., and Sood A.K. Therapeutic epha2 gene targeting in vivo using neutral liposomal small interfering RNA delivery. Cancer Res. 65 15 (2005) 6910-6918
11. Bangham A.D., Standish M.M., and Watkins J.C. Diffusion of univalent ions across the lamellae of swollen phospholipids. J. Mol. Biol. 13 1 (1965) 238-252
12. Massing U., and Fuxius S. Liposomal formulations of anticancer drugs: selectivity and effectiveness. Drug Resist. Updat. 3 3 (2000) 171-177
13. Moog R., Burger A.M., Brandl M., Schuler J., Schubert R., Unger C., Fiebig H.H., and Massing U. Change in pharmacokinetic and pharmacodynamic behavior of gemcitabine in human tumor xenografts upon entrapment in vesicular phospholipid gels. Cancer Chemother. Pharmacol. 49 5 (2002) 356-366
14. Rivera E. Liposomal anthracyclines in metastatic breast cancer: clinical update. Oncologist 8 Suppl 2 (2003) 3-9
15. Forssen E.A., Coulter D.M., and Proffitt R.T. Selective in vivo localization of daunorubicin small unilamellar vesicles in solid tumors. Cancer Res. 52 12 (1992) 3255-3261
16. Massing U. Cancer therapy with liposomal formulations of anticancer drugs. Int. J. Clin. Pharmacol. Ther. 35 2 (1997) 87-90
17. van Borssum Waalkes M., van Galen M., Morselt H., Sternberg B., and Scherphof G.L. In-vitro stability and cytostatic activity of liposomal formulations of 5-fluoro-2'-deoxyuridine and its diacylated derivatives. Biochim. Biophys. Acta 1148 1 (1993) 161-172
18. Gabizon A., and Papahadjopoulos D. Liposome formulations with prolonged circulation time in blood and enhanced uptake by tumors. Proc. Natl. Acad. Sci. U. S. A. 85 18 (1988) 6949-6953
19. Jain R.K. Transport of molecules in the tumor interstitium: a review. Cancer Res. 47 12 (1987) 3039-3051
20. Yuan F., Dellian M., Fukumura D., Leunig M., Berk D.A., Torchilin V.P., and Jain R.K. Vascular permeability in a human tumor xenograft: molecular size dependence and cutoff size. Cancer Res. 55 17 (1995) 3752-3756
21. Seymour L.W. Passive tumor targeting of soluble macromolecules and drug conjugates. Crit. Rev. Ther. Drug Carr. Syst. 9 2 (1992) 135-187
22. Devine D.V., Wong K., Serrano K., Chonn A., and Cullis P.R. Liposome-complement interactions in rat serum: implications for liposome survival studies. Biochim. Biophys. Acta 1191 1 (1994) 43-51
23. Patel H.M. Serum opsonins and liposomes: their interaction and opsonophagocytosis. Crit. Rev. Ther. Drug Carr. Syst. 9 1 (1992) 39-90
24. Papahadjopoulos D., Jacobson K., Nir S., and Isac T. Phase transitions in phospholipid vesicles. Fluorescence polarization and permeability measurements concerning the effect of temperature and cholesterol. Biochim. Biophys. Acta 311 3 (1973) 330-348
25. Torchilin V.P., Trubetskoy V.S., Whiteman K.R., Caliceti P., Ferruti P., and Veronese F.M. New synthetic amphiphilic polymers for steric protection of liposomes in vivo. J. Pharm. Sci. 84 9 (1995) 1049-1053
26. Papahadjopoulos D., Allen T.M., Gabizon A., Mayhew E., Matthay K., Huang S.K., Lee K.D., Woodle M.C., Lasic D.D., Redemann C., et al. Sterically stabilized liposomes: improvements in pharmacokinetics and antitumor therapeutic efficacy. Proc. Natl. Acad. Sci. U. S. A. 88 24 (1991) 11460-11464
27. Woodle M.C., Matthay K.K., Newman M.S., Hidayat J.E., Collins L.R., Redemann C., Martin F.J., and Papahadjopoulos D. Versatility in lipid compositions showing prolonged circulation with sterically stabilized liposomes. Biochim. Biophys. Acta 1105 2 (1992) 193-200
28. Allen T.M., Hansen C., Martin F., Redemann C., and Yau-Young A. Liposomes containing synthetic lipid derivatives of poly(ethylene glycol) show prolonged circulation half-lives in vivo. Biochim. Biophys. Acta 1066 1 (1991) 29-36
29. Berger N., Sachse A., Bender J., Schubert R., and Brandl M. Filter extrusion of liposomes using different devices: comparison of liposome size, encapsulation efficiency, and process characteristics. Int. J. Pharm. 223 1-2 (2001) 55-68
30. Brandl M. Vesicular phospholipid gels: a technology platform. J. Liposome Res. 17 1 (2007) 15-26
31. Safronova O.N. [differentiated approach to the evaluation of the asthmatic syndrome in acute pneumonias in young children]. Pediatr. Akus. Ginekol. 6 (1977) 18-20
32. Rhoden V., and Goldin S.M. Formation of unilamellar lipid vesicles of controllable dimensions by detergent dialysis. Biochemistry 18 19 (1979) 4173-4176
33. Mozafari M.R. Liposomes: an overview of manufacturing techniques. Cell. Mol. Biol. Lett. 10 4 (2005) 711-719
34. Massing U., Cicko S., and Ziroli V. Dual asymmetric centrifugation (dac)-a new technique for liposome preparation. J. Control. Release 125 1 (2008) 16-24
35. Jarve A., Muller J., Kim I.H., Rohr K., MacLean C., Fricker G., Massing U., Eberle F., Dalpke A., Fischer R., Trendelenburg M.F., and Helm M. Surveillance of sirna integrity by fret imaging. Nucleic Acids Res. 35 18 (2007) e124
36. Bornmann C., Graeser R., Esser N., Ziroli V., Jantscheff P., Keck T., Unger C., Hopt U.T., Adam U., Schaechtele C., Massing U., and von Dobschuetz E. A new liposomal formulation of gemcitabine is active in an orthotopic mouse model of pancreatic cancer accessible to bioluminescence imaging. Cancer Chemother. Pharmacol. 61 3 (2008) 395-405
37. Papahadjopoulos D., and Watkins J.C. Phospholipid model membranes. Ii. Permeability properties of hydrated liquid crystals. Biochim. Biophys. Acta 135 4 (1967) 639-652